Kaliumbromid Desitin

Potassium bromide, the active ingredient in Kaliumbromid Desitin, is a bromide presented as an oral formulation for oral use. It is used to manage seizure disorders, particularly epilepsy, in patients requiring adjunctive anticonvulsant therapy.

GNH USA supplies Kaliumbromid Desitin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaliumbromid Desitin (potassium bromide) is employed in the treatment of seizure disorders by enhancing neuronal inhibition.

- Generalized tonic‑clonic seizures: reduces frequency and severity of convulsive episodes. - Partial (focal) seizures: provides adjunctive control when other agents are insufficient. - Refractory epilepsy: offers an alternative mechanism for patients unresponsive to standard therapies.

Potassium bromide may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Drowsiness: mild to moderate sedation. - Ataxia: loss of coordination and balance. - Polyuria: increased urine output. - Polydipsia: excessive thirst. - Gastrointestinal upset: nausea or abdominal discomfort. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Severe depression or mood changes. - Respiratory depression: difficulty breathing. - Hepatic dysfunction: elevated liver enzymes. - Blood dyscrasias: leukopenia or thrombocytopenia. - Anaphylactic reaction: sudden swelling, hives, or airway compromise. - Stevens‑Johnson syndrome: severe skin blistering.

When prescribing potassium bromide, clinicians should consider several safety measures.

- Monitor serum bromide levels: ensure therapeutic range and avoid toxicity. - Assess renal function: impaired excretion can increase drug accumulation. - Evaluate hepatic status: liver disease may alter metabolism. - Avoid abrupt discontinuation: taper to prevent withdrawal seizures. - Check for hypersensitivity: discontinue if allergic reactions occur. - Store at ambient temperature: keep below 25°C in the original container, protected from moisture.

Potassium bromide can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Phenobarbital: induces metabolism, reducing bromide efficacy. - Valproic acid: may increase bromide toxicity. - Carbonic anhydrase inhibitors (e.g., acetazolamide): raise bromide concentrations.

Moderate Interactions (Monitor Closely): - Other CNS depressants (e.g., benzodiazepines): enhanced sedation. - Diuretics: alter bromide excretion, affecting levels. - Alcohol: additive central nervous system depression.